Product
Active Investigational Treatment ENT-01
1 clinical trial
2 indications
Indication
ConstipationIndication
Parkinson's diseaseClinical trial
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Multiple Dose Study to Evaluate Safety, Tolerability and Efficacy of Orally Administered ENT-01 for the Treatment of Parkinson's Disease-Related Constipation (KARMET)Status: Completed, Estimated PCD: 2021-12-14